Quants had a choppy 2025 and, now, a rough start to this year.

While having to navigate through the tariff uncertainty, investors also saw major ups and downs in the stock market. It is ...

Investors have plenty to be excited about as we kick off another year. With three consecutive double-digit return years in the market, many younger investors don’t really know much else other than ...

Eli Lilly's valuation has been driven higher by investor excitement around GLP-1 drugs, leaving other drugmakers languishing.

Now, it’s worth noting Stock Advisor’s total average return is 937 % — a market-crushing outperformance compared to 195% for ...

Major stock indexes were mixed on the final day of a volatile week of trading, while safe-haven gold and silver futures set ...

Donald Trump’s shortlived tariff threats reawaken fears over erratic policymaking that fuelled 2025 slump for US currency ...

Global equity funds captured significant investor interest in 2025, with passive index funds proving particularly popular for ...